Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 107

Similar articles for PubMed (Select 9537430)

1.

Defining the outcome of immunosuppression withdrawal after liver transplantation.

Devlin J, Doherty D, Thomson L, Wong T, Donaldson P, Portmann B, Williams R.

Hepatology. 1998 Apr;27(4):926-33.

PMID:
9537430
2.

The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.

Herzberg GZ, Rossi AF, Courtney M, Gelb BD.

J Heart Lung Transplant. 1998 Dec;17(12):1195-200.

PMID:
9883760
3.

Prospective study of microchimerism in renal allograft recipients: association between HLA-DR matching, microchimerism and acute rejection.

Tajik N, Singal D, Pourmand G, Ebrahimi-Rad M, Radjabzadeh M, Tavasoli P, Khosravi F, Nikbin B.

Clin Transplant. 2001 Jun;15(3):192-8.

PMID:
11389710
4.

Clinical transplantation tolerance twelve years after prospective withdrawal of immunosuppressive drugs: studies of chimerism and anti-donor reactivity.

Strober S, Benike C, Krishnaswamy S, Engleman EG, Grumet FC.

Transplantation. 2000 Apr 27;69(8):1549-54.

PMID:
10836360
5.

Role of HLA compatibility in pediatric living-related liver transplantation.

Kasahara M, Kiuchi T, Uryuhara K, Uemoto S, Fujimoto Y, Ogura Y, Oike F, Kaihara S, Egawa H, Tanaka K.

Transplantation. 2002 Oct 27;74(8):1175-80.

PMID:
12438966
6.

Effect of partial HLA class I match on acute rejection in viral pre-infected human liver allograft recipients.

Ontañón J, Muro M, García-Alonso AM, Minguela A, Torío A, Bermejo J, Pons JA, Campos M, Alvarez-López MR.

Transplantation. 1998 Apr 27;65(8):1047-53.

PMID:
9583864
7.

Allogeneic hematopoietic stem-cell transplantation, mixed chimerism, and tolerance in living related donor renal allograft recipients.

Trivedi HL, Vanikar AV, Modi PR, Shah VR, Vakil JM, Trivedi VB, Khemchandani SI.

Transplant Proc. 2005 Mar;37(2):737-42.

PMID:
15848518
8.

CMV hepatitis after liver transplantation: incidence, clinical course, and long-term follow-up.

Seehofer D, Rayes N, Tullius SG, Schmidt CA, Neumann UP, Radke C, Settmacher U, Müller AR, Steinmüller T, Neuhaus P.

Liver Transpl. 2002 Dec;8(12):1138-46.

9.

Long-term outcome of immunosuppression withdrawal after liver transplantation.

Girlanda R, Rela M, Williams R, O'Grady JG, Heaton ND.

Transplant Proc. 2005 May;37(4):1708-9.

PMID:
15919439
10.

Donor stem cell infusion after non-myeloablative conditioning for tolerance induction to HLA mismatched adult living-donor liver graft.

Donckier V, Troisi R, Toungouz M, Colle I, Van Vlierberghe H, Jacquy C, Martiat P, Stordeur P, Zhou L, Boon N, Lambermont M, Schandené L, Van Laethem JL, Noens L, Gelin M, de Hemptinne B, Goldman M.

Transpl Immunol. 2004 Sep-Oct;13(2):139-46.

PMID:
15380544
11.

Acute rejection of hepatic allografts from HLA-DR13 (Allele DRB1(*)1301)-positive donors.

Oertel M, Berr F, Schröder S, Schwarz R, Tannapfel A, Wenzke M, Lamesch P, Hauss J, Kohlhaw K.

Liver Transpl. 2000 Nov;6(6):728-33.

12.

Successful withdrawal of prednisone after adult liver transplantation for autoimmune hepatitis.

Trouillot TE, Shrestha R, Kam I, Wachs M, Everson GT.

Liver Transpl Surg. 1999 Sep;5(5):375-80.

PMID:
10477838
13.

Impact of human leukocyte antigen matching in liver transplantation.

Neumann UP, Guckelberger O, Langrehr JM, Lang M, Schmitz V, Theruvath T, Schonemann C, Menzel S, Klupp J, Neuhaus P.

Transplantation. 2003 Jan 15;75(1):132-7.

PMID:
12544885
14.

Randomized controlled trial of total immunosuppression withdrawal in liver transplant recipients: role of ursodeoxycholic acid.

Assy N, Adams PC, Myers P, Simon V, Minuk GY, Wall W, Ghent CN.

Transplantation. 2007 Jun 27;83(12):1571-6.

PMID:
17589339
15.

Molecular mechanisms associated with donor-specific microchimerism in peripheral blood of Brazilian patients after liver transplantation.

Araújo MB, Leonardi LS, Boin IF, Leonardi MI, Meirelles L, Magna LA, Donadi EA, Kraemer MH.

Transplant Proc. 2006 Jun;38(5):1411-7.

PMID:
16797319
16.

Long-term follow-up of donor chimerism and tolerance after human liver transplantation.

Ayala R, Grande S, Albizua E, Crooke A, Meneu JC, Moreno A, Pérez B, Gilsanz F, Moreno E, Martínez-Lopez J.

Liver Transpl. 2009 Jun;15(6):581-91. doi: 10.1002/lt.21736.

17.

Tolerance and latent cellular rejection in long-term liver transplant recipients.

Wong T, Nouri-Aria KT, Devlin J, Portmann B, Williams R.

Hepatology. 1998 Aug;28(2):443-9.

PMID:
9696010
18.

Does human leukocyte antigen matching influence the outcome of lung transplantation? An analysis of 3,549 lung transplantations.

Quantz MA, Bennett LE, Meyer DM, Novick RJ.

J Heart Lung Transplant. 2000 May;19(5):473-9.

PMID:
10808155
19.

Influence of donor/recipient HLA-matching on outcome and recurrence of hepatitis C after liver transplantation.

Langrehr JM, Puhl G, Bahra M, Schmeding M, Spinelli A, Berg T, Schönemann C, Krenn V, Neuhaus P, Neumann UP.

Liver Transpl. 2006 Apr;12(4):644-51.

20.

Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome.

Flomenberg N, Baxter-Lowe LA, Confer D, Fernandez-Vina M, Filipovich A, Horowitz M, Hurley C, Kollman C, Anasetti C, Noreen H, Begovich A, Hildebrand W, Petersdorf E, Schmeckpeper B, Setterholm M, Trachtenberg E, Williams T, Yunis E, Weisdorf D.

Blood. 2004 Oct 1;104(7):1923-30. Epub 2004 Jun 10.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk